Absci to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has announced its participation in two upcoming investor conferences in April 2025:

• H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference - Fireside chat scheduled for Wednesday, April 2 at 10:30 a.m. ET / 7:30 a.m. PT
• 24th Annual Needham Virtual Healthcare Conference - Fireside chat scheduled for Tuesday, April 8 at 3:45 p.m. ET / 12:45 p.m. PT

Investors and interested parties can access both live and archived webcasts of these fireside chat sessions through Absci's investor relations website at investors.absci.com.

VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.

• H.C. Wainwright 2^nd Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
  Fireside chat on Wednesday, April 2 at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time

• 24^th Annual Needham Virtual Healthcare Conference
  Fireside chat on Tuesday, April 8 at 3:45 p.m. Eastern Time / 12:45 p.m. Pacific Time

Interested parties may access live and archived webcasts of the fireside chat sessions on the company’s investor relations website at: investors.absci.com.

About Absci

Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.

Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com

Media Contact
press@absci.com

FAQ

When is Absci (ABSI) presenting at the H.C. Wainwright AI Drug Discovery Conference in 2025?

Absci will present at the H.C. Wainwright Conference on Wednesday, April 2, 2025, at 10:30 a.m. Eastern Time.

What time is Absci's (ABSI) presentation at the Needham Healthcare Conference 2025?

Absci will present at the Needham Healthcare Conference on Tuesday, April 8, 2025, at 3:45 p.m. Eastern Time.

How can investors watch Absci's (ABSI) investor conference presentations?

Investors can access live and archived webcasts of the presentations through Absci's investor relations website at investors.absci.com.

Which investor conferences is Absci (ABSI) attending in April 2025?

Absci is participating in the H.C. Wainwright AI Drug Discovery Conference on April 2 and the Needham Virtual Healthcare Conference on April 8, 2025.